Ionis Pharmaceuticals, Inc. IONS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

46/100

3/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Ionis Pharmaceuticals, Inc. (IONS), dont 21 achats et 29 ventes. Le total des achats d'initiés s'élève à $634.42K et le total des ventes d'initiés à $22.21M.

Les initiés notables ayant une activité récente comprennent Devers Shannon L., Klein Joseph Iii, Schneider Eugene. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — IONS

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-04-02	Devers Shannon L.	EVP, Chief Human Resources Ofc	Vente Informative	6,193	$74.05	$458.61K	16,348
2026-04-01	Klein Joseph Iii	Director	Exercice d'Options (Vente)	10,321	$41.08	$423.99K	-
2026-03-19	Schneider Eugene	EVP, Chf Clinical Develop Ofcr	Vente Informative	5,812	$70.97	$412.49K	63,890
2026-03-17	Hougen Elizabeth L	EVP, Finance & CFO	Vente Informative	10,172	$73.21	$744.66K	82,660
2026-03-16	Hougen Elizabeth L	EVP, Finance & CFO	Exercice d'Options (Vente)	33,118	$32.60	$1.08M	-
2026-03-04	Loscalzo Joseph	Director	Exercice d'Options (Vente)	200	$38.06	$7.61K	10,968
2026-03-04	Baroldi Joseph	EVP, Chief Business Officer	Exercice d'Options (Vente)	201	$32.60	$6.55K	1,769
2026-03-03	Bennett C Frank	EVP, Chief Scientific Officer	Exercice d'Options (Vente)	48,626	$60.89	$2.96M	-
2026-03-03	Klein Joseph Iii	Director	Exercice d'Options (Vente)	4,000	$42.88	$171.52K	-
2026-03-03	Loscalzo Joseph	Director	Exercice d'Options (Vente)	832	$38.06	$31.67K	11,168
2026-03-03	Diaz Allene M.	Director	Exercice d'Options (Vente)	10,321	$41.08	$423.99K	-
2026-03-03	Baroldi Joseph	EVP, Chief Business Officer	Exercice d'Options (Vente)	879	$32.60	$28.66K	1,970
2026-03-03	Devers Shannon L.	EVP, Chief Human Resources Ofc	Exercice d'Options (Vente)	6,951	$32.60	$226.6K	928
2026-02-27	Bennett C Frank	EVP, Chief Scientific Officer	Autre (Achat)	261	$48.87	$12.75K	100,554
2026-02-27	Monia Brett P	Chief Executive Officer	Autre (Achat)	484	$48.87	$23.65K	254,981
2026-02-27	O'neil Patrick R.	EVP CLO & General Counsel	Autre (Achat)	376	$48.87	$18.37K	72,359
2026-02-27	Swayze Eric	EVP Research	Autre (Achat)	256	$48.87	$12.51K	32,361
2026-02-27	Birchler Brian	EVP, Corp and Development Ops	Autre (Achat)	351	$48.87	$17.15K	66,598
2026-02-13	Swayze Eric	EVP Research	Vente Informative	6,207	$82.07	$509.4K	32,105
2026-02-11	Parshall B Lynne	Director	Vente Informative	5,000	$82.72	$413.59K	56,344
2026-02-06	Monia Brett P	Chief Executive Officer	Vente Informative	29,430	$85.79	$2.52M	254,497
2026-02-02	Bennett C Frank	EVP, Chief Scientific Officer	Exercice d'Options (Vente)	48,626	$60.89	$2.96M	-
2026-02-02	Bennett C Frank	EVP, Chief Scientific Officer	Autre (Vente)	-	-	-	100,293
2026-01-30	Hougen Elizabeth L	EVP, Finance & CFO	Vente Informative	6,988	$83.24	$581.7K	132,881
2026-01-30	Monia Brett P	Chief Executive Officer	Vente Informative	62,970	$82.72	$5.21M	283,927
2026-01-30	O'neil Patrick R.	EVP CLO & General Counsel	Vente Informative	6,179	$83.53	$516.15K	71,983
2026-01-30	Swayze Eric	EVP Research	Vente Informative	6,179	$82.93	$512.45K	47,747
2026-01-30	Schneider Eugene	EVP, Chf Clinical Develop Ofcr	Vente Informative	6,179	$83.45	$515.63K	69,702
2026-01-29	Hougen Elizabeth L	EVP, Finance & CFO	Attribution de RSU	13,562	-	-	139,869
2026-01-29	Monia Brett P	Chief Executive Officer	Attribution de RSU	122,214	-	-	346,897
2026-01-29	O'neil Patrick R.	EVP CLO & General Counsel	Attribution de RSU	11,991	-	-	78,162
2026-01-29	Swayze Eric	EVP Research	Attribution de RSU	11,991	-	-	53,926
2026-01-29	Schneider Eugene	EVP, Chf Clinical Develop Ofcr	Attribution de RSU	11,991	-	-	75,881
2026-01-29	Birchler Brian	EVP, Corp and Development Ops	Attribution de RSU	11,991	-	-	72,426
2025-05-01	Hayden Michael R	Director	Achat Informatif	15,000	$31.86	$477.9K	50,219
2025-04-16	Jenne Kyle	EVP, Chf Gl Pdt Str Ofcr	Vente Informative	3,016	$28.36	$85.53K	11,199
2025-04-16	Baroldi Joseph	EVP, Chief Business Officer	Vente Informative	3,928	$28.40	$111.56K	31,926
2025-04-16	Birchler Brian	EVP, Corp and Development Ops	Vente Informative	680	$28.37	$19.29K	56,660
2025-04-15	Jenne Kyle	EVP, Chf Gl Pdt Str Ofcr	Exercice d'Options	12,226	-	-	14,215
2025-04-15	Baroldi Joseph	EVP, Chief Business Officer	Exercice d'Options	10,837	-	-	35,854
2025-04-15	Birchler Brian	EVP, Corp and Development Ops	Exercice d'Options	1,875	-	-	57,340
2025-03-11	Monia Brett P	Chief Executive Officer	Vente Informative	140	$32.32	$4.52K	180,980
2025-02-28	Bennett C Frank	EVP, Chief Scientific Officer	Autre (Achat)	320	$28.21	$9.03K	93,466
2025-02-28	Geary Richard S	EVP, Chief Development Officer	Autre (Achat)	415	$28.21	$11.71K	99,492
2025-02-28	Monia Brett P	Chief Executive Officer	Autre (Achat)	437	$28.21	$12.33K	181,120
2025-02-28	O'neil Patrick R.	EVP CLO & General Counsel	Autre (Achat)	554	$28.21	$15.63K	56,799
2025-02-28	Swayze Eric	EVP Research	Autre (Achat)	415	$28.21	$11.71K	48,432
2025-02-28	Birchler Brian	EVP, Corp and Development Ops	Autre (Achat)	414	$28.21	$11.68K	55,465
2025-02-20	O'neil Patrick R.	EVP CLO & General Counsel	Vente Informative	1,207	$32.35	$39.05K	56,245
2025-02-04	Monia Brett P	Chief Executive Officer	Vente Informative	38,843	$31.65	$1.23M	180,683

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration